ClinicalTrials.Veeva

Menu

Diffusion-tensor Imaging in Brain Tumors Evaluation

G

George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures (UMFST)

Status

Unknown

Conditions

MRI
Diffusion Tensor Imaging
Tractography

Treatments

Diagnostic Test: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05261724
GEPaladeU

Details and patient eligibility

About

Primary and secondary brain tumors are challenging pathologies regarding diagnosis and treatment. MRI is widely used in the imaging evaluation and surgical planning, due to its spatial resolution and ability of tissular characterization.

In this study patients with suspected brain tumors, confirmed by routine MRI evaluation (T1, T2, T2*, FLAIR, T1 with contrast sequences) will undergo DWI and DTI evaluation. By analyzing collected data from MRI evaluation and patient records regarding surgical and histopathological data our aim is to investigate derived imaging biomarkers with impact in the surgical planning and rehabilitation of the patients.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • brain tumors confirmed by routine MRI evaluation
  • surgical treatment with histopathological diagnosis

Exclusion criteria

  • MRI contraindications
  • past or present neurological or neurosurgical condition, beside the tumor
  • pregnancy

Trial design

100 participants in 2 patient groups

Patients with primary brain tumors
Treatment:
Diagnostic Test: MRI
Patients with secondary brain tumors
Treatment:
Diagnostic Test: MRI

Trial contacts and locations

1

Loading...

Central trial contact

Mircea Buruian; Mihail Porutiu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems